Application 214566
- Type
- NDA
- Sponsor
- AB PHARMACEUTICALS, LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOLUTEGRAVIR SODIUM | DOLUTEGRAVIR SODIUM | TABLET; ORAL SUSPENSION | 10MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tivicay | DOLUTEGRAVIR SODIUM | ST. MARY'S MEDICAL PARK PHARMACY | 485bc9db-8665-9f5a-e063-6394a90a7921 | 2026-05-22 | Warnings, Adverse reactions | DOLUTEGRAVIR SODIUM |
| Tivicay | DOLUTEGRAVIR SODIUM | ViiV Healthcare Company | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 2025-10-29 | Warnings, Adverse reactions | DOLUTEGRAVIR SODIUM |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 66801 | ORIG | 2021-03-17 |